Literature DB >> 24481857

Maintenance of luminal pH and protease activity in lysosomes/late endosomes by vacuolar ATPase in chlorpromazine-treated RAW264 cells accumulating phospholipids.

Ryohei Hamaguchi1, Jun Haginaka, Toshiko Tanimoto, Yukihiro Kuroda.   

Abstract

Cationic amphiphilic drugs (CADs) inhibit phospholipases competitively/uncompetitively. It has also been reported that CADs spontaneously accumulate in acidic organelles and increase their luminal pH, which may lead to deactivation of phospholipid-metabolising enzymes, causing cellular phospholipid accumulation. Recently, however, contradictory results have also been reported in that the luminal pH is not increased by CAD treatment. In this study, we examined whether the lysosomal/late endosomal acidic pH was maintained by vacuolar ATPase (v-ATPase) after treatment with chlorpromazine (CPZ) as a model CAD. The activity of lysosomal protease after CPZ treatment was also measured. Oregon Green-dextran-tetramethylrhodamine conjugate was employed to determine the luminal pH of the lysosomes/late endosomes in RAW264 cells. The luminal pH remained acidic after treatment with CPZ for 23 h, and the lysosomal protease activity was not decreased by 5-min CPZ treatment. Co-treatment with CPZ and bafilomycin A1 (v-ATPase inhibitor) raised the luminal pH. These results suggest that the lysosomal/late endosomal pH is not affected by a 23-h CPZ treatment. In addition, lysosomal enzymes presumably maintain their activity when CPZ accumulates. Our results imply that the pH homeostasis in lysosomes/late endosomes is strictly maintained even after a longer treatment with CADs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24481857     DOI: 10.1007/s10565-014-9269-2

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  4 in total

Review 1.  Lysosomal Stress Response (LSR): Physiological Importance and Pathological Relevance.

Authors:  Koffi L Lakpa; Nabab Khan; Zahra Afghah; Xuesong Chen; Jonathan D Geiger
Journal:  J Neuroimmune Pharmacol       Date:  2021-03-22       Impact factor: 4.147

2.  Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2.

Authors:  Tia A Tummino; Veronica V Rezelj; Benoit Fischer; Audrey Fischer; Matthew J O'Meara; Blandine Monel; Thomas Vallet; Ziyang Zhang; Assaf Alon; Henry R O'Donnell; Jiankun Lyu; Heiko Schadt; Kris M White; Nevan J Krogan; Laszlo Urban; Kevan M Shokat; Andrew C Kruse; Adolfo García-Sastre; Olivier Schwartz; Francesca Moretti; Marco Vignuzzi; Francois Pognan; Brian K Shoichet
Journal:  bioRxiv       Date:  2021-03-24

3.  Environmental concentrations of Roundup in combination with chlorpromazine or heating causes biochemical disturbances in the bivalve mollusc Unio tumidus.

Authors:  Vira Khoma; Viktoria Martinyuk; Tetyana Matskiv; Lesya Gnatyshyna; Vitaliy Baranovsky; Mykola Gladiuk; Brigita Gylytė; Levonas Manusadžianas; Oksana Stoliar
Journal:  Environ Sci Pollut Res Int       Date:  2021-10-03       Impact factor: 4.223

4.  Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.

Authors:  Tia A Tummino; Veronica V Rezelj; Benoit Fischer; Audrey Fischer; Matthew J O'Meara; Blandine Monel; Thomas Vallet; Kris M White; Ziyang Zhang; Assaf Alon; Heiko Schadt; Henry R O'Donnell; Jiankun Lyu; Romel Rosales; Briana L McGovern; Raveen Rathnasinghe; Sonia Jangra; Michael Schotsaert; Jean-René Galarneau; Nevan J Krogan; Laszlo Urban; Kevan M Shokat; Andrew C Kruse; Adolfo García-Sastre; Olivier Schwartz; Francesca Moretti; Marco Vignuzzi; Francois Pognan; Brian K Shoichet
Journal:  Science       Date:  2021-06-22       Impact factor: 47.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.